| http://www.w3.org/ns/prov#value | - This event is a rare chance to hear from industry policy experts about what effect decisions in Washington could have on your bottom line, with sessions including The Reimbursement Landscape Under ACA. In addition to the business roundtables and therapeutic workshops, the opening and closing plenary sessions will offer a look at the state of capital markets for biotech and what that means for comp
|
